In addition, in hepatocellular carcinoma, miR-219 also acts as a tumor suppressor that was found to be significantly downregulated and to be able to suppress cell proliferation by targeting glypican-3 [36]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.